At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
ketaminedrug
Likely dose
ketamine 0.4 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Role of CYP2B6 Polymorphisms in Ketamine Metabolism and Clearance
In Brief
A clinical study evaluating ketamine for Healthy Volunteers. Completed, enrolled 30 participants across 1 site.
Detailed Summary
This research study will determine if genetic variation in CYP2B6 affects how the body metabolizes ketamine.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteers
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartNov 2013
First PostedNov 2013
Primary CompletionMay 2016
Study CompletionMay 2017
TodayJul 2026
First PostedNov 20, 2013
Enrollment StartNov 1, 2013
Primary CompletionMay 1, 2016
Study CompletionMay 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 12.6 years ago
Interventions
ketaminedrug
0.4 mg/kg oral racemic ketamine